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Pseudomonas putida is a promising bacterial chassis for metabolic engineering given its ability to metabolize a wide array of carbon sources, especially aromatic
compounds derived from lignin. However, this omnivorous metabolism can also be a hindrance when it can naturally metabolize products produced from engineered
pathways. Herein we show that P. putida is able to use valerolactam as a sole carbon source, as well as degrade caprolactam. Lactams represent important nylon
precursors, and are produced in quantities exceeding one million tons per year (Zhang et al., 2017). To better understand this metabolism we use a combination of
Random Barcode Transposon Sequencing (RB-TnSeq) and shotgun proteomics to identify the oplBA locus as the likely responsible amide hydrolase that initiates
valerolactam catabolism. Deletion of the oplBA genes prevented P. putida from growing on valerolactam, prevented the degradation of valerolactam in rich media, and
dramatically reduced caprolactam degradation under the same conditions. Deletion of oplBA, as well as pathways that compete for precursors L-lysine or 5-amino-
valerate, increased the titer of valerolactam from undetectable after 48 h of production to ~90mg/L. This work may serve as a template to rapidly eliminate un-
desirable metabolism in non-model hosts in future metabolic engineering efforts.1. Introduction
Pseudomonas putida has attracted great attention as a potential chassis
organism for metabolic engineering due in large part to its ability to
metabolize a wide variety of carbon sources, particularly aromatic
compounds that can be derived from lignin (Loeschcke and Thies, 2015;
Ravi et al., 2017). To more fully realize this vision, much effort has been
put forth recently to better characterize the central metabolism of
P. putida with updated genome-scale models (Nogales et al., 2017), C13
ﬂux experiments (Kukurugya et al., 2019; Nikel et al., 2015), and
high-throughput ﬁtness assays, which have all contributed to a more
complete understanding of the bacterium (Thompson et al., 2019a; Rand* Corresponding author. Center for Synthetic Biochemistry, Institute for Synthetic
E-mail address: keasling@berkeley.edu (J.D. Keasling).
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KT2440 for increased product titer, Metabolic Engineering Communicationet al., 2017). Despite these advances, the metabolic capabilities of
P. putida are not yet fully understood.
One consequence of this omnivorous metabolism is that P. putida
possesses the ability to degrade or fully catabolize chemicals metabolic
engineers seek to produce in the host. An ongoing challenge for P. putida
host engineering is to rapidly identify catabolic pathways of important
target molecules and eliminate them from the genome. The recent report
of a novel pathway for levulinic acid catabolism in P. putida KT2440
underscores the catabolic ﬂexibility of the host, and an additional
obstacle towards producing high product titer (Rand et al., 2017). While
challenging, this is not surprising; as a genus, Pseudomonads are well
known for their ability to degrade a wide range of naturally occurring orBiology, Shenzhen Institutes for Advanced Technologies, Shenzhen, China
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Caprolactam and valerolactam are both important commodity
chemicals used in the synthesis of nylon polymers, with global produc-
tion of caprolactam reaching over four million metric tons (Zhang et al.,
2017). Multiple efforts have been made to produce these chemicals
biologically, with the titers of valerolactam approaching 1 g/L in
Escherichia coli (Zhang et al., 2017; Chae et al., 2017). The engineered
pathway to valerolactam in E. coli converts L-lysine to 5-aminovalerate
(5AVA) via DavBA, two genes endogenous to P. putida, and then cy-
clizes it via a promiscuous coA-ligase (Zhang et al., 2017). While the
endogenous L-lysine catabolism of P. putida has been leveraged to pro-
duce the C5 diacid glutarate, there has yet to be any attempt to produce
valerolactam in the bacterium (Zhang et al., 2018). It has previously been
put forth that P. putida can catabolize valerolactam and caprolactam
(Belda et al., 2016). Furthermore, a recent report that Pseudomonas jes-
senii can catabolize caprolactam suggested that catabolism of lactams
could dramatically impact titers of valerolactam in P. putida (Otzen et al.,
2018).
In this work we demonstrate that P. putida can utilize valerolactam as
a sole carbon source, as well as degrade caprolactam. Using a combina-
tion of Random Barcode Transposon Sequencing (RB-TnSeq) and shotgun
proteomics we were able to identify that OplBA, a predicted oxoproli-
nase, is responsible for this hydrolysis. By knocking out oplBA in addition
to two pathways that compete for precursors we were able to increase theFigure 1. Identiﬁcation of the P. putida valerolactam hydrolase: (A) Route of valerol
P. putida in minimal medium supplemented with either 10mM glucose, 5AVA, or
Maximal growth rates (1/hr) were 0.29 on glucose, 0.29 on 5AVA, and 0.21 on val
grown on either 5AVA or valerolactam as a sole carbon source. Red oval shows th
proteomics of proteins found in the supernatant of P. putida grown on either 10mM g
number of proteins with an exponentially modiﬁed protein abundance index (emP
Table shows the most abundant proteins speciﬁc to grown on valerolactam. OplA (Q
2titers of valerolactam in P. putida.
2. Results
2.1. Identiﬁcation of a lactam hydrolase in P. putida
The hydrolysis product of valerolactam is 5AVA, an intermediate in L-
lysine metabolism (Fig. 1A). Growth curves of P. putida on valerolactam
as a sole carbon source demonstrated that the bacteriumwas readily able
to catabolize valerolactam and produce biomass, with growth similar to
that on either 5AVA and glucose (Fig. 1B). P. putida was also able to use
both valerolactam and caprolactam as a sole nitrogen source (Fig. S1).
Initially, we attempted to identify the enzyme responsible for valer-
olactam hydrolysis using RB-TnSeq, a technique that has previously been
used to identify novel enzymes in D-lysine metabolism (Thompson et al.,
2019a). RB-TnSeq measures the relative ﬁtness of transposon mutant
pools to infer gene function through changes in relative abundance of all
non-essential genes in a bacterium under a selective condition (Wetmore
et al., 2015; Price et al., 2018). Mutant pools of P. putida were grown on
either 5AVA or valerolactam as a sole carbon source in an attempt to
identify enzymes solely essential for growth on valerolactam. Results of
RB-TnSeq experiments suggested that valerolactam was indeed being
catabolized through the same pathway as 5AVA with both conditions
showing signiﬁcant defects in the davTD and csiD-lghO operons, theactam catabolism through the L-lysine catabolic route of P. putida (B) Growth of
valerolactam. Shaded area represents the 95% conﬁdence interval (cI), n¼ 3.
erolactam. (C) RB-TnSeq analysis of genome ﬁtness assays of P. putida libraries
e predicted ﬁtness result of a valerolactam hydrolase. (D) Results of shotgun
lucose or 10mM valerolactam as a sole carbon source. Venn diagram shows the
AI) relative abundance above 0.1 shared or unique to each carbon source (E)
88H50_PSEPK) and OplB (Q88H51_PSEPK) are in bold.
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there were no genes that showed obvious ﬁtness defects only under the
valerolactam growth condition (Fig. 1C).
The inability of the RB-TnSeq approach to identify the hydrolytic
enzyme could result from the enzyme being secreted from the cell. In this
case, the secreted enzymes from cells containing the intact hydrolase
gene produce 5AVA which can freely diffuse into hydrolase mutant cells,
eliminating any selective pressure for lactam-based growth. To test
whether the enzymes responsible for lactam hydrolysis may be secreted,
cultures of P. putida were either grown on glucose or valerolactam as a
sole carbon source, their supernatants ﬁltered, concentrated, and then
subjected to shotgun proteomics. Of the most abundant proteins in the
supernatant, there were 25 proteins that were speciﬁc to glucose, while
46 were speciﬁc to valerolactam, with 86 proteins being shared between
the two conditions (Fig. 1D). Within the top ﬁve most abundant proteins
in the valerolactam supernatant were OplB (Q88H51_PSEPK) and OplA
(Q88H51_PSEPK), which together are annotated as the two subunits of a
5-oxoprolinase, orthologs of which have been suggested to participate in
the caprolactam catabolism of P. jessenii (Fig. 1E) (Otzen et al., 2018).
Additional shotgun proteomics of cell pellets grown on either glucose,
5AVA, or valerolactam showed that OplB and OplA were more highly
expressed in the presence of the lactam in comparison to the other carbon
sources (Fig. S2C). Interestingly, ﬁtness data from two valerolactam
RB-TnSeq experiments in P. putida KT2440 show oplBA mutants having
no signiﬁcant ﬁtness defects (Fig. S2B). Orthologs of oplBA are widely
distributed across many bacteria including other attractive metabolic
engineering chassis such as Rhodococcus opacus, and are nearly always
located adjacent to one another on the genome (Fig. S3).2.2. Deletion of oplBA mitigates consumption of valerolactam and
caprolactam
To conﬁrm the role of OplBA in the catabolism of valerolactam, de-
letions were constructed of the oplBA locus in P. putida via homologousFigure 2. OplBA controls valerolactam and caprolactam degradation in P. putida. Gro
10mM glucose (A), 5-aminovaleroate (B), or valerolactam (C). (D) Remaining butyrol
P. putida, wild-type, or a ΔoplBA mutant.
3recombination. Growth of the mutant was compared to the wild type as
well as to a deletion mutant of davT, which catalyzes the ﬁrst step in
5AVA catabolism. All strains showed identical growth on glucose as a
sole carbon source (Fig. 2A). In the presence of 5AVA the oplBA deletion
strain showed no growth defect compared to the wild-type, while the
davT mutant predictably was unable to grow (Fig. 2B). However, on
valerolactam only the wild type strain grew, while both the oplBA and
davTmutants showed no measurable growth after 40 h (Fig. 2C). Growth
rates of strains on all carbon sources are reported in Table S1. Comple-
mentation of oplBA mutants with oplBA expressed from a plasmid
restored growth on valerolactam, while a sham plasmid expressing RFP
was unable to grow (Fig. S4). These results suggest that OplBA is the sole
enzyme responsible for the conversion of valerolactam to 5AVA under
these conditions.
While P. putida KT2440 can utilize valerolactam as a sole carbon
source, it is unable to grow on caprolactam (data not shown). In order to
determine whether the OplBA of P. putida is capable of degrading other
lactams, wild type and ΔoplBA strains were grown in LB medium sup-
plemented with 10mM caprolactam, valerolactam, or butyrolactam for
24 h after which the remaining lactam concentration was compared to an
uninoculated medium control. Wild type P. putida consumed all detect-
able valerolactam within 24 h, and less than 50% of both butyrolactam
and caprolactam remained compared to the uninoculated control
(Fig. 2D). There was no signiﬁcant decrease in amount of valerolactam in
the ΔoplBA cultures compared to the uninoculated control (t-test of
p¼ 0.178), though there was a slight but signiﬁcant decrease of 0.74mM
caprolactam (t-test of p¼ 0.033). No butyrolactam remained in the
ΔoplBA culture after 24 h (Fig. 2D). This result was surprising as the
annotated substrate of OplBA, 5-oxoproline, has the same ring size as
butyrolactam. Previous work has shown that homologs of OplBA are
ATP-dependent amidohydrolases that hydrolyze 5-oxoproline (Seddon
et al., 1985). However, when puriﬁed OplBA was incubated with valer-
olactam in addition to ATP and magnesium we observed no hydrolysis
relative to boiled enzyme controls (Fig. S5).wth of wild-type, ΔdavT, or ΔoplBA in minimal media supplemented with either
actam, valerolactam, or caprolactam in LB medium after 24-h incubation with no
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The published pathway for the production of valerolactam from L-
lysine in E. coli utilized the formation of 5AVA via the davBA pathway
native to P. putida, followed by cyclization to the lactam via a promis-
cuous acyl-coA ligase from Streptomyces aizunensis (Fig. 3A) (Zhang et al.,
2017). To produce valerolactam in P. putida, not only will the production
pathway need to be overexpressed, but the oplBA locus and pathways
that compete for 5AVA must be eliminated. Loss of ﬂux to valerolactam
occurs through two known competing pathways: the Alr-mediated
isomerization to D-lysine or catabolism of 5AVA to glutarate via the ac-
tion of DavTD (Fig. 3A) (Thompson et al., 2019a).
To investigate the relative contributions of pathways that contribute
to either lactam hydrolysis or loss of substrate, we expressed the davBA-
ORF26 pathway via a arabinose-inducible broad host range vector
pBADT in backgrounds where these pathways had been sequentially
deleted. Wild type P. putida produced 0.43mg/L valerolactam after 24 h,
but no valerolactam could be detected after 48 h, presumably due to host
consumption (Fig. 3B). Simple deletion of the oplBA locus resulted in a410-fold increase of production at 24 h to 4.47mg/L and a 48-h titer of
9.27mg/L (Fig. 3B). Additional deletion of davT resulted in an increase of
titer to 19.29mg/L and 85.19mg/L, and by deleting the amino acid
racemase alr titers increased to 63.66mg/L and 91.97mg/L at 24 and
48 h, respectively (Fig. 3B).
3. Discussion
Recent economic analyses highlight the necessity of lignin valoriza-
tion to create a sustainable bioeconomy (Baral et al., 2019; Becker and
Wittmann, 2019). With its robust aromatic metabolism combined with
novel methods of biomass deconstruction, P. putida has great potential to
convert lignocellulosic biomass to value-added products (Rodriguez
et al., 2017; Kohlstedt et al., 2018). Though the ability of P. putida to
catabolize many carbon sources is often viewed as an asset, it has well
documented metabolic pathways to degrade many compounds that
metabolic engineers may wish to produce such as levulinic acid (Rand
et al., 2017), various alcohols (Wehrmann et al., 2017), and the diacid
glutarate (Zhang et al., 2018). As these catabolic phenotypes areFigure 3. Production of valerolactam in P. putida: (A)
Design of valerolactam producing P. putida. The
biosynthetic pathway genes are shown in green and
were overexpressed heterologously from a pBBR ori
plasmid using an arabinose inducible promoter.
Pathways that catabolize products or divert precursors
are shown in red. (B) Valerolactam production from
different P. putida strains grown in LB medium sup-
plemented with 25mM L-lysine and 0.2% (w/v)
arabinose at 24 and 48 h post inoculation. Error bars
show 95% cI, n¼ 3.
Table 1
Strains and plasmids used in this study.
Strain JBEI Part ID Reference
E. coli DH10B Grant et al. (1990)
E. coli BL21(DE3) Novagen
P. putida KT2440 ATCC 47054
P. putida ΔdavT Thompson et al. (2019b)
P. putida ΔoplBA JPUB_013576 This work
P. putida ΔoplBAΔdavT JPUB_013577 This work
P. putida ΔoplBAΔdavTΔalr JPUB_013578 This work
Plasmids
pET28 Novagen
pET28 oplA JPUB_013579 This work
pET28 oplB JPUB_013581 This work
pBADT Bi et al. (2013)
pBADT-davBA-ORF26 JPUB_013587 This work
pBADT-oplBA JPUB_013620 This work
pMQ30 Shanks et al. (2009)
pMQ30 oplBA JPUB_013585 This work
pMQ30 alr JPUB_013583 This work
pMQ30 davT Thompson et al. (2019b)
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loci.
The recent surge in development of functional genomics techniques
has dramatically increased the throughput at which we can identify the
genetic basis of unknown metabolism. RB-TnSeq has been used to un-
cover novel glutarate and levulinic acid metabolism, though was inef-
fective at identifying the oplBA locus (Thompson et al., 2019a; Rand
et al., 2017). Proteomics techniques have also grown more robust, and
were used in P. jessenii to predict a route of caprolactam catabolism
(Otzen et al., 2018; Chen et al., 2019). Here, proteomics also proved to be
an effective means of identifying the enzyme responsible for the hydro-
lysis of the lactam. Our proteomics results showed that OplBA was spe-
ciﬁcally expressed when grown on valerolactam, but not 5AVA. These
results suggest that P. putida may have lactam-speciﬁc transcription
factors which could be developed into valuable tools for metabolic en-
gineering if identiﬁed.
The inability of RB-TnSeq to identify these genes is curious as single
deletion mutants were unable to grow on valerolactam. A possible
explanation for this is that OplBA may be secreted, which would create a
public pool of 5AVA which oplBA mutants could still utilize. However,
OplBA orthologs have been shown to be ATP-dependent (Seddon et al.,
1985), which would be inconsistent with this extracellular localization.
Unfortunately our attempts to characterize OplBA in vitro were unsuc-
cessful, preventing us from identifying the substrate requirements of the
enzyme. Though we were unable to reconstitute the activity of OplBA in
vitro, deletion of oplBA did not prevent the degradation of butyrolactam
which is a 5-membered lactam ring. The annotated function of the oplBA
loci is a 5-oxoprolinase, which hydrolyzes the 5-membered lactam ring of
5-oxoproline. These results may suggest that the OplBA may function
naturally as something other than a 5-oxoprolinase. More work will be
necessary to resolve the results of our RB-TnSeq and feeding experiments
to elucidate the biochemical requirements of OplBA as well as to better
understand its cellular localization.
To achieve titers of ~90mg/Lwe supplementedmedia with 25mML-
lysine (3.65 g/L). Previous work in E. coli achieved titers of ~200mg/L
by feeding 1 g/L lysine and ~300mg/L by feeding 5 g/L after 48 h
(Zhang et al., 2017). Our results indicate that with signiﬁcant host en-
gineering, P. putida can produce titers approaching those of model or-
ganisms. Optimization of pathway expression could narrow this gap even
further and should be a focus of future efforts.
While this initial work is encouraging, it still requires the feeding of L-
lysine in rich media for conversion to valerolactam. Ideally, engineering
P. putida would be able to metabolize lignin hydrolysis products directly
to L-lysine on the way to the ﬁnal product. A great deal of work has been
conducted to elucidate the complex catabolism of lysine in P. putida
(Thompson et al., 2019a; Zhang et al., 2018), yet relatively little work has
been done to increase ﬂux to lysine within the bacterium.While there has
been little to divert ﬂux to L-lysine in P. putida, there is a wealth of evi-
dence in other bacteria where high titers of intracellular lysine have been
achieved (Nærdal et al., 2011; Rajvanshi et al., 2013). The ever
increasing body of research to characterize the sprawling metabolism of
P. putida will greatly aid in future efforts of efﬁcient production of
valerolactam from lignocellulosic feedstocks.
4. Methods
4.1. Media, chemicals, and culture conditions
General E. coli cultures were grown in lysogeny broth (LB) Miller
medium (BD Biosciences, USA) at 37 C while P. putida was grown at
30 C. When indicated, P. putida and E. coli were grown on modiﬁed
MOPS minimal medium, which is comprised of 32.5 μM CaCl2, 0.29mM
K2SO4, 1.32mM K2HPO4, 8 μM FeCl2, 40mM MOPS, 4mM tricine,
0.01mM FeSO4, 9.52mM NH4Cl, 0.52mMMgCl2, 50mM NaCl, 0.03 μM
(NH4)6Mo7O24, 4 μM H3BO3, 0.3 μM CoCl2, 0.1 μM CuSO4, 0.8 μM
MnCl2, and 0.1 μM ZnSO4 (LaBauve and Wargo, 2012). Cultures were5supplemented with kanamycin (50mg/L, Sigma Aldrich, USA), genta-
micin (30mg/L, Fisher Scientiﬁc, USA), or carbenicillin (100mg/L,
Sigma Aldrich, USA), when indicated. All other compounds were pur-
chased through Sigma Aldrich (Sigma Aldrich, USA).
4.2. Strains and plasmids
All bacterial strains and plasmids used in this work are listed in
Table 1. All strains and plasmids created in this work are available
through the public instance of the JBEI registry. (public-registry.jbei.o
rg/folders/456). All plasmids were designed using Device Editor and
Vector Editor software, while all primers used for the construction of
plasmids were designed using j5 software (Ham et al., 2012; Chen et al.,
2012; Hillson et al., 2012). Plasmids were assembled via Gibson As-
sembly using standard protocols (Gibson et al., 2009), or Golden Gate
Assembly using standard protocols (Engler et al., 2008). Plasmids were
routinely isolated using the Qiaprep Spin Miniprep kit (Qiagen, USA),
and all primers were purchased from Integrated DNA Technologies (IDT,
Coralville, IA). Construction of P. putida deletion mutants was performed
as described previously (Thompson et al., 2019a).
4.3. Plate based growth assays
Growth studies of bacterial strains were conducted a microplate
reader kinetic assays. Overnight cultures were inoculated into 10mL of
LBmedium from single colonies, and grown at 30 C. These cultures were
then washed twice with MOPS minimal media without any added carbon
and diluted 1:100 into 500 μL of MOPS medium with 10mM of a carbon
source in 48-well plates (Falcon, 353072). Plates were sealed with a gas-
permeable microplate adhesive ﬁlm (VWR, USA), and then optical den-
sity and ﬂuorescence were monitored for 48 h in an Biotek Synergy 4
plate reader (BioTek, USA) at 30 C with fast continuous shaking. Optical
density was measured at 600 nm.
4.4. Production assays and lactam quantiﬁcation
To assess valerolactam production in strains of P. putida overnight
cultures of strains harboring pBADT-davBA-ORF26 were grown in 3mL
of LB supplemented with kanamycin and grown at 30 C. Production
cultures of 10mL of LB supplemented with kanamycin, 25mM L-lysine,
and 0.2% w/v arabinose were then inoculated 1:100 with overnight
cultures and then grown at 30 C shaking at 250 rpm. Samples for
valerolactam production were taken at 24 and 48 h post-inoculation,
with 200 μL of culture being quenched with an equal volume of ice
cold methanol and then stored at 20 C until analysis.
For measurement of lactams, liquid chromatographic separation was
M.G. Thompson et al. Metabolic Engineering Communications xxx (xxxx) xxxconducted at 20 C with a Kinetex HILIC column (50-mm length, 4.6-mm
internal diameter, 2.6-μm particle size; Phenomenex, Torrance, CA)
using a 1260 Series HPLC system (Agilent Technologies, Santa Clara, CA,
USA). The injection volume for each measurement was 5 μL. The mobile
phase was composed of 10mM ammonium formate and 0.07% formic
acid in water (solvent A) and 10mM ammonium formate and 0.07%
formic acid in 90% acetonitrile and 10% water (solvent B) (HPLC grade,
Honeywell Burdick & Jackson, CA, USA). High purity ammonium
formate and formic acid (98–100% chemical purity) were purchased
from Sigma-Aldrich, St. Louis, MO, USA. Lactams were separated with
the following gradient: decreased from 90%B to 70%B in 2min, held at
70%B for 0.75min, decreased from 70%B to 40%B in 0.25min, held at
40%B for 1.25min, increased from 40%B to 90%B for 0.25min, held at
90%B for 1min. The ﬂow rate was varied as follows: 0.6mL/min for
3.25min, increased from 0.6mL/min to 1mL/min in 0.25min, and held
at 1mL/min for 2min. The total run time was 5.5 min.
The HPLC system was coupled to an Agilent Technologies 6520
quadrupole time-of-ﬂight mass spectrometer (QTOF MS) with a 1:6 post-
column split. Nitrogen gas was used as both the nebulizing and drying gas
to facilitate the production of gas-phase ions. The drying and nebulizing
gases were set to 12 L/min and 30 lb/in2, respectively, and a drying gas
temperature of 350 C was used throughout. Fragmentor, skimmer and
OCT 1 RF voltages were set to 100 V, 50 V and 300 V, respectively.
Electrospray ionization (ESI) was conducted in the positive-ion mode for
the detection of [M þ H]þ ions with a capillary voltage of 4000 V. The
collision energy voltage was set to 0 V. MS experiments were carried out
in the full-scan mode (75–1100 m/z) at 0.86 spectra/s. The QTOF-MS
system was tuned with the Agilent ESI-L Low concentration tuning mix
in the range of 50–1700 m/z. Lactams were quantiﬁed by comparison
with 8-point calibration curves of authentic chemical standards from
0.78125 μM to 100 μM. R2 coefﬁcients of 0.99[EB1] were achieved for
the calibration curves. Data acquisition was performed by Agilent
MassHunter Workstation (version B.05.00), qualitative assessment by
Agilent MassHunter Qualitative Analysis (version B.05.00 or B.06.00),
and data curation by Agilent Proﬁnder (version B.08.00).
4.5. RB-TnSeq and proteomics analysis
RB-TnSeq experiments utilized P. putida library JBEI-1 which has
been described previously (Thompson et al., 2019a). Libraries of JBEI-1
were thawed on ice, diluted into 25mL of LB medium with kanamycin
and then grown to an OD600 of 0.5 at 30 C at which point three 1mL
aliquots were removed, pelleted, and stored at 80 C. Libraries were
then washed once in MOPS minimal medium with no carbon source, and
then diluted 1:50 in MOPS minimal medium with 10mM valerolactam.
Cells were grown in 500 μL of medium in 48-well plates (Falcon,
353072). Plates were sealed with a gas-permeable microplate adhesive
ﬁlm (VWR, USA), and then grown at 30 C in a Tecan Inﬁnite F200
microplate reader (Tecan Life Sciences, San Jose, CA), with shaking at
200 rpm. Two 500 μL aliquots were combined, pelleted, and stored at
80 C until BarSeq analysis, which was performed as previously
described (Rand et al., 2017; Wetmore et al., 2015). All ﬁtness data is
publically available at http://fit.genomics.lbl.gov.
Secreted proteins of P. putida were prepared by growing 500mL of
culture in MOPS minimal medium supplemented with either 10mM
glucose or 10mM valerolactam for 24 h at 30 C, which were subse-
quently pelleted and ﬁltered through a 0.22 μm ﬁlter and then concen-
trated 100x via a 10 kD MW cutoff ﬁlter. Cultures for intracellular
proteomics analysis were grown in 10mL cultures in the same conditions
on either glucose, 5AVA, or valerolactam and were then pelleted and
stored at 80 C until sample workup and proteomic analysis. Proteins
from secreted and intracellular samples were desalted and isolated using
a variation of a previously-described chloroform/methanol extraction
protocol (Wessel and Flügge, 1984). For secreted proteins, 100–200 μL of
the concentrated protein sample was used; for intracellular samples, cell
pellets were thoroughly resuspended in 100 μL HPLC water. Then, the6following reagents were added to each sample in sequential order with
thorough vortexing after each addition: 400 μL of HPLC grade methanol,
100 μL of HPLC grade chloroform, 300 μL of HPLC grade water. Samples
were centrifuged for 1min at ~21,000 g in order to promote phase
separation. After centrifugation, the entirety of the top layer (water and
methanol) was removed and discarded, leaving on the protein pellet and
chloroform layer remaining. Another 300 μL of HPLC grade methanol
was added, then the samples were vortexed and centrifuged again for
2min at ~21,000 g. The remaining liquid was then removed and dis-
carded, and the cell pellets were allowed to dry in a fume hood for 5min.
Protein pellets were then resuspended in freshly-prepared 100mM
ammonium bicarbonate buffer in HPLC water containing 20% HPLC
methanol. Protein concentrations in the resuspended samples were
quantiﬁed using a DC Protein Assay Kit (Bio-Rad Laboratories, Hercules,
CA). After quantiﬁcation, 100 μg of protein was transferred to a PCR strip
and tris(2-carboxyethyl)phosphine was added to a ﬁnal concentration of
5mM. Samples were incubated at 22 C for 30min, after which iodoa-
cetamide was added (ﬁnal concentration 10mM). Samples were again
incubated at 22 C in the dark for 30min. Finally, trypsin was added to a
ﬁnal ratio of 1:25 w/w trypsin:sample, and samples were digested at
37 C for 5–8 h before being transferred to conical LC vials for LC-MS
analysis. Peptides prepared for shotgun proteomic experiments were
analyzed by using an Agilent 6550 iFunnel Q-TOF mass spectrometer
(Agilent Technologies, Santa Clara, CA) coupled to an Agilent 1290
UHPLC system as described previously (Gonzalez Fernandez-Ni~no et al.,
2015). 20 μg of peptides were separated on a Sigma–Aldrich Ascentis
Peptides ES-C18 column (2.1mm 100mm, 2.7 μm particle size, oper-
ated at 60 C) at a 0.400mL/min ﬂow rate and eluted with the following
gradient: initial condition was 98% solvent A (0.1% formic acid v/v) and
2% solvent B (99.9% acetonitrile, 0.1% formic acid v/v). Solvent B was
increased to 35% over 30min, and then increased to 80% over 2min,
then held for 6min, followed by a ramp back down to 2% B over 1min
where it was held for 4min to re-equilibrate the column to original
conditions. Peptides were introduced to the mass spectrometer from the
LC by using a Jet Stream source (Agilent Technologies) operating in
positive-ion mode (3500 V). Source parameters employed gas temp
(250 C), drying gas (14 L/min), nebulizer (35 psig), sheath gas temp
(250 C), sheath gas ﬂow (11 L/min), VCap (3500 V), fragmentor
(180 V), OCT 1 RF Vpp (750 V). The data were acquired with Agilent
MassHunter Workstation Software, LC/MS Data Acquisition B.06.01
operating in Auto MS/MS mode whereby the 20 most intense ions
(charge states, 2–5) within 300–1400m/z mass range above a threshold
of 1500 counts were selected for MS/MS analysis. MS/MS spectra
(100–1700m/z) were collected with the quadrupole set to “Medium”
resolution and were acquired until 45,000 total counts were collected or
for a maximum accumulation time of 333ms. Former parent ions were
excluded for 0.1min following MS/MS acquisition. The acquired data
were exported as mgf ﬁles and searched against the latest P. putida
KT2440 protein database with Mascot search engine version 2.3.02
(Matrix Science). The resulting search results were ﬁltered and analyzed
by Scaffold v 4.3.0 (Proteome Software Inc.).4.6. Protein puriﬁcation and biochemical analysis of OplBA
Both oplB and oplA were cloned into the expression vector pET28
harboring N-terminal 6x-histidine puriﬁcation tags. Protein expression
and puriﬁcation were carried out as described previously (Thompson
et al., 2019a). To characterize activity of OplBA we used conditions that
were previously described to characterize 5-oxoprolinase with minor
changes (Li et al., 1988). Brieﬂy, 10 μM of each OplB and OplA or boiled
controls were incubated for 4 h at 30 C with 2mM valerolactam in
100mM Tris-HCl pH 7.0, 4mM MgCl2, with or without 2mM ATP. Re-
actions were quenched with ice-cold methanol, ﬁltered through a 3 kDa
MWCO ﬁlter, diluted 40-fold with 50% methanol/50% H2O v/v, and
stored at - 20 C until analysis via LC-MS.
M.G. Thompson et al. Metabolic Engineering Communications xxx (xxxx) xxx4.7. Bioinformatic analyses
All statistical analyses were carried out using either the Python Scipy
or Numpy libraries (Jones, Oliphant, Peterson; van der Walt et al., 2011).
For the phylogenetic reconstructions, the best amino acid substitution
model was selected using ModelFinder as implemented on IQ-tree
(Kalyaanamoorthy et al., 2017) phylogenetic trees were constructed
using IQ-tree, nodes were supported with 10,000 bootstrap replicates.
The ﬁnal tree ﬁgures were edited using FigTree v1.4.3 (http://tree.bio.e
d.ac.uk/software/ﬁgtree/). Orthologous syntenic regions of OplBA were
identiﬁed with CORASON-BGC (Cruz-Morales et al., 2017) and manually
colored and annotated.
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